Managing children with chronic myeloid leukaemia (CML): recommendations for the management of CML in children and young people up to the age of 18 years.
about
Leukostasis in Children and Adolescents with Chronic Myeloid Leukemia: Japanese Pediatric Leukemia/Lymphoma Study Group.The role of stem cell transplantation for chronic myelogenous leukemia in the 21st centuryIndications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015.Epidemiology of chronic myeloid leukaemia: an update.Tyrosine kinase inhibitor therapy in chronic myeloid leukemia: update on key adverse events.Recognizing Endocrinopathies Associated With Tyrosine Kinase Inhibitor Therapy in Children With Chronic Myelogenous Leukemia.Incidence and survival time trends for Spanish children and adolescents with leukaemia from 1983 to 2007.Can chronic myeloid leukaemia in children and adolescents be successfully treated without haematopoietic stem cell transplant? A single centre experience.Prognostic discrimination based on the EUTOS long term survival score within the international registry for chronic myeloid leukemia in children and adolescents.Can prognostic scoring systems for chronic myeloid leukemia as established in adults be applied to pediatric patients?Response dynamics of pediatric patients with chronic myeloid leukemia on imatinib therapy.The impact of early molecular response in children and adolescents with chronic myeloid leukemia treated with imatinib: a single-center study from China.Long-term results of high-dose imatinib in children and adolescents with chronic myeloid leukaemia in chronic phase: the Italian experience.Pharmacology and pharmacokinetics of imatinib in pediatric patients.Breastfeeding in Patients with Chronic Myeloid Leukaemia: Case Series with Measurements of Drug Concentrations in Maternal Milk and Literature Review.Ph-negative isolated myeloid sarcoma with NPM1 gene mutation in adolescent with Ph-positive chronic myeloid leukemia in remission after treatment with allogeneic bone marrow transplantation and imatinib mesylate.Sustained complete molecular remission after imatinib discontinuation in children with chronic myeloid leukemia.Optimal management for pediatric chronic myeloid leukemia.MiRNA Dysregulation in Childhood Hematological Cancer
P2860
Q33166364-C5BA5A9F-F47A-4DF2-A005-EEB8ECEA93E7Q35634865-6124D853-2E8F-4854-A16D-93BC3F7206E3Q38387292-E3D77841-6470-498B-8E57-7DD651D9B31AQ38392709-C04C5441-7D5B-4BF5-8ECA-E778AD651BECQ38457554-C946DC54-BA61-4823-91C9-6CD95BEA5986Q38813874-8C22CB80-78D0-4C09-AE63-346A85DD8EEDQ39570532-F07C6D8A-9A62-4D83-A555-22674C69ABEDQ39969896-C1CC847F-968C-4D9B-AF9E-C9DC1DB40681Q40071286-4E5CCBAD-E4AC-41D6-91F4-53DB85D9CC60Q41038941-2AA9CA45-C118-423D-B027-49823E4C288EQ42325011-0BA462FB-ECF9-4E2A-AA7F-8D84ED8B1F70Q48243531-1FD67F29-E0CF-4753-ABF5-A5C6A2783453Q49101349-99B6A928-EF74-4EEB-A69A-76CD4C983109Q50094239-69CD228D-58E0-4C61-A8CC-857E52CC648EQ54110129-2876E541-9B0A-4203-B5E0-D94F75BBE66CQ54294058-38311960-5489-4352-A93D-8BAACA90B9E2Q54354157-B3D0F1CD-2D5D-4787-AEE1-B96F754E60B4Q55034870-FB83BA49-8A90-432A-A118-FA54D0CD84C1Q58753107-AE31A553-1248-4569-819C-56C5D68ADB8B
P2860
Managing children with chronic myeloid leukaemia (CML): recommendations for the management of CML in children and young people up to the age of 18 years.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Managing children with chronic ...... ple up to the age of 18 years.
@en
Managing children with chronic myeloid leukaemia
@nl
type
label
Managing children with chronic ...... ple up to the age of 18 years.
@en
Managing children with chronic myeloid leukaemia
@nl
prefLabel
Managing children with chronic ...... ple up to the age of 18 years.
@en
Managing children with chronic myeloid leukaemia
@nl
P2093
P2860
P356
P1476
Managing children with chronic ...... ple up to the age of 18 years.
@en
P2093
Andrea Biondi
André Baruchel
Eveline de Bont
Frédéric Millot
International BFM Group (iBFM) Study Group Chronic Myeloid Leukaemia Committee
Josu de la Fuente
Marie-Françoise Dresse
Meinolf Suttorp
P2860
P356
10.1111/BJH.12977
P407
P577
2014-06-30T00:00:00Z